Found 136 hits of Enzyme Inhibition Constant Data Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176751
(8-(1-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)-1H-py...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccccc2)c1 Show InChI InChI=1S/C23H24N8O3/c1-3-10-30-21-18(22(32)31(11-4-2)23(30)33)26-19(27-21)16-12-24-29(13-16)14-17-25-20(28-34-17)15-8-6-5-7-9-15/h5-9,12-13H,3-4,10-11,14H2,1-2H3,(H,26,27) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50233091
(8-(1-((5-phenylisoxazol-3-yl)methyl)-1H-pyrazol-4-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccccc2)c1 Show InChI InChI=1S/C24H25N7O3/c1-3-10-30-22-20(23(32)31(11-4-2)24(30)33)26-21(27-22)17-13-25-29(14-17)15-18-12-19(34-28-18)16-8-6-5-7-9-16/h5-9,12-14H,3-4,10-11,15H2,1-2H3,(H,26,27) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 14 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176739
(4-(3-((4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydr...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccc(cc2)C#N)c1 Show InChI InChI=1S/C24H23N9O3/c1-3-9-32-21-19(23(34)33(10-4-2)24(32)35)28-20(29-21)17-12-26-31(13-17)14-18-27-22(36-30-18)16-7-5-15(11-25)6-8-16/h5-8,12-13H,3-4,9-10,14H2,1-2H3,(H,28,29) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 14 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176757
(4-(5-((4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydr...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccc(cc2)C#N)c1 Show InChI InChI=1S/C24H23N9O3/c1-3-9-32-22-19(23(34)33(10-4-2)24(32)35)28-20(29-22)17-12-26-31(13-17)14-18-27-21(30-36-18)16-7-5-15(11-25)6-8-16/h5-8,12-13H,3-4,9-10,14H2,1-2H3,(H,28,29) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 18 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176769
(8-(1-((3-(2-chlorophenyl)-1,2,4-oxadiazol-5-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccccc2Cl)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-9-31-21-18(22(33)32(10-4-2)23(31)34)27-19(28-21)14-11-25-30(12-14)13-17-26-20(29-35-17)15-7-5-6-8-16(15)24/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,27,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 19 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176740
(8-(1-((3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccc(Cl)cc2)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-9-31-21-18(22(33)32(10-4-2)23(31)34)27-19(28-21)15-11-25-30(12-15)13-17-26-20(29-35-17)14-5-7-16(24)8-6-14/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,27,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 21 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176738
(1,3-dipropyl-8-(1-((5-(4-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccc(cc2)C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-9-34-20-18(22(36)35(10-4-2)23(34)37)30-19(31-20)15-11-28-33(12-15)13-17-29-21(38-32-17)14-5-7-16(8-6-14)24(25,26)27/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,30,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 21 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50233109
(8-(1-((5-phenyl-1,2,4-oxadiazol-3-yl)methyl)-1H-py...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccccc2)c1 Show InChI InChI=1S/C23H24N8O3/c1-3-10-30-20-18(22(32)31(11-4-2)23(30)33)26-19(27-20)16-12-24-29(13-16)14-17-25-21(34-28-17)15-8-6-5-7-9-15/h5-9,12-13H,3-4,10-11,14H2,1-2H3,(H,26,27) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 21 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176736
(CHEMBL200780 | N-(2-chlorophenyl)-2-(4-(2,6-dioxo-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(CC(=O)Nc2ccccc2Cl)c1 Show InChI InChI=1S/C22H24ClN7O3/c1-3-9-29-20-18(21(32)30(10-4-2)22(29)33)26-19(27-20)14-11-24-28(12-14)13-17(31)25-16-8-6-5-7-15(16)23/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,25,31)(H,26,27) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| 22 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176752
(8-(1-((3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2cccc(Cl)c2)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-8-31-21-18(22(33)32(9-4-2)23(31)34)27-19(28-21)15-11-25-30(12-15)13-17-26-20(29-35-17)14-6-5-7-16(24)10-14/h5-7,10-12H,3-4,8-9,13H2,1-2H3,(H,27,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 32 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176768
(8-(1-((5-(2-chlorophenyl)-1,2,4-oxadiazol-3-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccccc2Cl)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-9-31-20-18(22(33)32(10-4-2)23(31)34)27-19(28-20)14-11-25-30(12-14)13-17-26-21(35-29-17)15-7-5-6-8-16(15)24/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,27,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 38 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176748
(8-(1-((5-(4-chlorophenyl)-1,2,4-oxadiazol-3-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccc(Cl)cc2)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-9-31-20-18(22(33)32(10-4-2)23(31)34)27-19(28-20)15-11-25-30(12-15)13-17-26-21(35-29-17)14-5-7-16(24)8-6-14/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,27,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 39 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176737
(1,3-dipropyl-8-(1-((3-(3-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2cccc(c2)C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-8-34-21-18(22(36)35(9-4-2)23(34)37)30-19(31-21)15-11-28-33(12-15)13-17-29-20(32-38-17)14-6-5-7-16(10-14)24(25,26)27/h5-7,10-12H,3-4,8-9,13H2,1-2H3,(H,30,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 42 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176755
(1,3-dipropyl-8-(1-((5-(4-(trifluoromethyl)phenyl)i...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccc(cc2)C(F)(F)F)c1 Show InChI InChI=1S/C25H24F3N7O3/c1-3-9-34-22-20(23(36)35(10-4-2)24(34)37)30-21(31-22)16-12-29-33(13-16)14-18-11-19(38-32-18)15-5-7-17(8-6-15)25(26,27)28/h5-8,11-13H,3-4,9-10,14H2,1-2H3,(H,30,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 48 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176767
(1,3-dipropyl-8-(1-((3-p-tolyl-1,2,4-oxadiazol-5-yl...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccc(C)cc2)c1 Show InChI InChI=1S/C24H26N8O3/c1-4-10-31-22-19(23(33)32(11-5-2)24(31)34)27-20(28-22)17-12-25-30(13-17)14-18-26-21(29-35-18)16-8-6-15(3)7-9-16/h6-9,12-13H,4-5,10-11,14H2,1-3H3,(H,27,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 54 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176756
(1,3-dipropyl-8-(1-((3-(4-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccc(cc2)C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-9-34-21-18(22(36)35(10-4-2)23(34)37)30-19(31-21)15-11-28-33(12-15)13-17-29-20(32-38-17)14-5-7-16(8-6-14)24(25,26)27/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,30,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176763
(8-(1-((5-(4-methoxyphenyl)isoxazol-3-yl)methyl)-1H...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccc(OC)cc2)c1 Show InChI InChI=1S/C25H27N7O4/c1-4-10-31-23-21(24(33)32(11-5-2)25(31)34)27-22(28-23)17-13-26-30(14-17)15-18-12-20(36-29-18)16-6-8-19(35-3)9-7-16/h6-9,12-14H,4-5,10-11,15H2,1-3H3,(H,27,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 63 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176759
(1,3-dipropyl-8-(1-((5-(3-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2cccc(c2)C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-8-34-20-18(22(36)35(9-4-2)23(34)37)30-19(31-20)15-11-28-33(12-15)13-17-29-21(38-32-17)14-6-5-7-16(10-14)24(25,26)27/h5-7,10-12H,3-4,8-9,13H2,1-2H3,(H,30,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 64 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176742
(1,3-dipropyl-8-(1-((3-(2-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccccc2C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-9-34-21-18(22(36)35(10-4-2)23(34)37)30-19(31-21)14-11-28-33(12-14)13-17-29-20(32-38-17)15-7-5-6-8-16(15)24(25,26)27/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,30,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 74 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176754
(8-(1-((5-(4-chlorophenyl)isoxazol-3-yl)methyl)-1H-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccc(Cl)cc2)c1 Show InChI InChI=1S/C24H24ClN7O3/c1-3-9-31-22-20(23(33)32(10-4-2)24(31)34)27-21(28-22)16-12-26-30(13-16)14-18-11-19(35-29-18)15-5-7-17(25)8-6-15/h5-8,11-13H,3-4,9-10,14H2,1-2H3,(H,27,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 82 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176745
(8-(1-((3-(2-methoxyphenyl)-1,2,4-oxadiazol-5-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccccc2OC)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-10-31-22-19(23(33)32(11-5-2)24(31)34)27-20(28-22)15-12-25-30(13-15)14-18-26-21(29-36-18)16-8-6-7-9-17(16)35-3/h6-9,12-13H,4-5,10-11,14H2,1-3H3,(H,27,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 82 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176749
(8-(1-((3-(3-methoxyphenyl)-1,2,4-oxadiazol-5-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2cccc(OC)c2)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-9-31-22-19(23(33)32(10-5-2)24(31)34)27-20(28-22)16-12-25-30(13-16)14-18-26-21(29-36-18)15-7-6-8-17(11-15)35-3/h6-8,11-13H,4-5,9-10,14H2,1-3H3,(H,27,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 82 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176762
(8-(1-((5-(2-methoxyphenyl)-1,2,4-oxadiazol-3-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccccc2OC)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-10-31-21-19(23(33)32(11-5-2)24(31)34)27-20(28-21)15-12-25-30(13-15)14-18-26-22(36-29-18)16-8-6-7-9-17(16)35-3/h6-9,12-13H,4-5,10-11,14H2,1-3H3,(H,27,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 83 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176743
(1,3-dipropyl-8-(1-((5-(2-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccccc2C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-9-34-20-18(22(36)35(10-4-2)23(34)37)30-19(31-20)14-11-28-33(12-14)13-17-29-21(38-32-17)15-7-5-6-8-16(15)24(25,26)27/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,30,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176736
(CHEMBL200780 | N-(2-chlorophenyl)-2-(4-(2,6-dioxo-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(CC(=O)Nc2ccccc2Cl)c1 Show InChI InChI=1S/C22H24ClN7O3/c1-3-9-29-20-18(21(32)30(10-4-2)22(29)33)26-19(27-20)14-11-24-28(12-14)13-17(31)25-16-8-6-5-7-15(16)23/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,25,31)(H,26,27) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| 102 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176744
(8-(1-((3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccc(OC)cc2)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-10-31-22-19(23(33)32(11-5-2)24(31)34)27-20(28-22)16-12-25-30(13-16)14-18-26-21(29-36-18)15-6-8-17(35-3)9-7-15/h6-9,12-13H,4-5,10-11,14H2,1-3H3,(H,27,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 106 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176761
(8-(1-((5-(2-chlorophenyl)isoxazol-3-yl)methyl)-1H-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccccc2Cl)c1 Show InChI InChI=1S/C24H24ClN7O3/c1-3-9-31-22-20(23(33)32(10-4-2)24(31)34)27-21(28-22)15-12-26-30(13-15)14-16-11-19(35-29-16)17-7-5-6-8-18(17)25/h5-8,11-13H,3-4,9-10,14H2,1-2H3,(H,27,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 111 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176750
(1,3-dipropyl-8-(1-((5-(2-(trifluoromethyl)phenyl)i...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccccc2C(F)(F)F)c1 Show InChI InChI=1S/C25H24F3N7O3/c1-3-9-34-22-20(23(36)35(10-4-2)24(34)37)30-21(31-22)15-12-29-33(13-15)14-16-11-19(38-32-16)17-7-5-6-8-18(17)25(26,27)28/h5-8,11-13H,3-4,9-10,14H2,1-2H3,(H,30,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 121 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176747
(8-(1-((5-(4-methoxyphenyl)-1,2,4-oxadiazol-3-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccc(OC)cc2)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-10-31-21-19(23(33)32(11-5-2)24(31)34)27-20(28-21)16-12-25-30(13-16)14-18-26-22(36-29-18)15-6-8-17(35-3)9-7-15/h6-9,12-13H,4-5,10-11,14H2,1-3H3,(H,27,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 123 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176766
(1,3-dipropyl-8-(1-((3-m-tolyl-1,2,4-oxadiazol-5-yl...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2cccc(C)c2)c1 Show InChI InChI=1S/C24H26N8O3/c1-4-9-31-22-19(23(33)32(10-5-2)24(31)34)27-20(28-22)17-12-25-30(13-17)14-18-26-21(29-35-18)16-8-6-7-15(3)11-16/h6-8,11-13H,4-5,9-10,14H2,1-3H3,(H,27,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 128 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176765
(8-(1-((5-(3-methoxyphenyl)isoxazol-3-yl)methyl)-1H...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2cccc(OC)c2)c1 Show InChI InChI=1S/C25H27N7O4/c1-4-9-31-23-21(24(33)32(10-5-2)25(31)34)27-22(28-23)17-13-26-30(14-17)15-18-12-20(36-29-18)16-7-6-8-19(11-16)35-3/h6-8,11-14H,4-5,9-10,15H2,1-3H3,(H,27,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 131 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176746
(8-(1-((5-(3-chlorophenyl)-1,2,4-oxadiazol-3-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2cccc(Cl)c2)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-8-31-20-18(22(33)32(9-4-2)23(31)34)27-19(28-20)15-11-25-30(12-15)13-17-26-21(35-29-17)14-6-5-7-16(24)10-14/h5-7,10-12H,3-4,8-9,13H2,1-2H3,(H,27,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 134 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176741
(8-(1-((5-(3-methoxyphenyl)-1,2,4-oxadiazol-3-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2cccc(OC)c2)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-9-31-21-19(23(33)32(10-5-2)24(31)34)27-20(28-21)16-12-25-30(13-16)14-18-26-22(36-29-18)15-7-6-8-17(11-15)35-3/h6-8,11-13H,4-5,9-10,14H2,1-3H3,(H,27,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 136 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176764
(8-(1-((5-(3-chlorophenyl)isoxazol-3-yl)methyl)-1H-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2cccc(Cl)c2)c1 Show InChI InChI=1S/C24H24ClN7O3/c1-3-8-31-22-20(23(33)32(9-4-2)24(31)34)27-21(28-22)16-12-26-30(13-16)14-18-11-19(35-29-18)15-6-5-7-17(25)10-15/h5-7,10-13H,3-4,8-9,14H2,1-2H3,(H,27,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 163 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2b
(Homo sapiens (Human)) | BDBM50176753
(8-(1-((5-(2-methoxyphenyl)isoxazol-3-yl)methyl)-1H...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccccc2OC)c1 Show InChI InChI=1S/C25H27N7O4/c1-4-10-31-23-21(24(33)32(11-5-2)25(31)34)27-22(28-23)16-13-26-30(14-16)15-17-12-20(36-29-17)18-8-6-7-9-19(18)35-3/h6-9,12-14H,4-5,10-11,15H2,1-3H3,(H,27,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 195 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2B receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176768
(8-(1-((5-(2-chlorophenyl)-1,2,4-oxadiazol-3-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccccc2Cl)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-9-31-20-18(22(33)32(10-4-2)23(31)34)27-19(28-20)14-11-25-30(12-14)13-17-26-21(35-29-17)15-7-5-6-8-16(15)24/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,27,28) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 330 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176742
(1,3-dipropyl-8-(1-((3-(2-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccccc2C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-9-34-21-18(22(36)35(10-4-2)23(34)37)30-19(31-21)14-11-28-33(12-14)13-17-29-20(32-38-17)15-7-5-6-8-16(15)24(25,26)27/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,30,31) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 340 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176751
(8-(1-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)-1H-py...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccccc2)c1 Show InChI InChI=1S/C23H24N8O3/c1-3-10-30-21-18(22(32)31(11-4-2)23(30)33)26-19(27-21)16-12-24-29(13-16)14-17-25-20(28-34-17)15-8-6-5-7-9-15/h5-9,12-13H,3-4,10-11,14H2,1-2H3,(H,26,27) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 370 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176740
(8-(1-((3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccc(Cl)cc2)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-9-31-21-18(22(33)32(10-4-2)23(31)34)27-19(28-21)15-11-25-30(12-15)13-17-26-20(29-35-17)14-5-7-16(24)8-6-14/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,27,28) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 400 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176745
(8-(1-((3-(2-methoxyphenyl)-1,2,4-oxadiazol-5-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccccc2OC)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-10-31-22-19(23(33)32(11-5-2)24(31)34)27-20(28-22)15-12-25-30(13-15)14-18-26-21(29-36-18)16-8-6-7-9-17(16)35-3/h6-9,12-13H,4-5,10-11,14H2,1-3H3,(H,27,28) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 410 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50233091
(8-(1-((5-phenylisoxazol-3-yl)methyl)-1H-pyrazol-4-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccccc2)c1 Show InChI InChI=1S/C24H25N7O3/c1-3-10-30-22-20(23(32)31(11-4-2)24(30)33)26-21(27-22)17-13-25-29(14-17)15-18-12-19(34-28-18)16-8-6-5-7-9-16/h5-9,12-14H,3-4,10-11,15H2,1-2H3,(H,26,27) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 420 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176751
(8-(1-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)-1H-py...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccccc2)c1 Show InChI InChI=1S/C23H24N8O3/c1-3-10-30-21-18(22(32)31(11-4-2)23(30)33)26-19(27-21)16-12-24-29(13-16)14-17-25-20(28-34-17)15-8-6-5-7-9-15/h5-9,12-13H,3-4,10-11,14H2,1-2H3,(H,26,27) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 480 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176752
(8-(1-((3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2cccc(Cl)c2)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-8-31-21-18(22(33)32(9-4-2)23(31)34)27-19(28-21)15-11-25-30(12-15)13-17-26-20(29-35-17)14-6-5-7-16(24)10-14/h5-7,10-12H,3-4,8-9,13H2,1-2H3,(H,27,28) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 490 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176769
(8-(1-((3-(2-chlorophenyl)-1,2,4-oxadiazol-5-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccccc2Cl)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-9-31-21-18(22(33)32(10-4-2)23(31)34)27-19(28-21)14-11-25-30(12-14)13-17-26-20(29-35-17)15-7-5-6-8-16(15)24/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,27,28) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 490 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176742
(1,3-dipropyl-8-(1-((3-(2-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccccc2C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-9-34-21-18(22(36)35(10-4-2)23(34)37)30-19(31-21)14-11-28-33(12-14)13-17-29-20(32-38-17)15-7-5-6-8-16(15)24(25,26)27/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,30,31) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 530 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176754
(8-(1-((5-(4-chlorophenyl)isoxazol-3-yl)methyl)-1H-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccc(Cl)cc2)c1 Show InChI InChI=1S/C24H24ClN7O3/c1-3-9-31-22-20(23(33)32(10-4-2)24(31)34)27-21(28-22)16-12-26-30(13-16)14-18-11-19(35-29-18)15-5-7-17(25)8-6-15/h5-8,11-13H,3-4,9-10,14H2,1-2H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 540 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176739
(4-(3-((4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydr...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccc(cc2)C#N)c1 Show InChI InChI=1S/C24H23N9O3/c1-3-9-32-21-19(23(34)33(10-4-2)24(32)35)28-20(29-21)17-12-26-31(13-17)14-18-27-22(36-30-18)16-7-5-15(11-25)6-8-16/h5-8,12-13H,3-4,9-10,14H2,1-2H3,(H,28,29) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 570 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176749
(8-(1-((3-(3-methoxyphenyl)-1,2,4-oxadiazol-5-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2cccc(OC)c2)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-9-31-22-19(23(33)32(10-5-2)24(31)34)27-20(28-22)16-12-25-30(13-16)14-18-26-21(29-36-18)15-7-6-8-17(11-15)35-3/h6-8,11-13H,4-5,9-10,14H2,1-3H3,(H,27,28) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 600 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176743
(1,3-dipropyl-8-(1-((5-(2-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccccc2C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-9-34-20-18(22(36)35(10-4-2)23(34)37)30-19(31-20)14-11-28-33(12-14)13-17-29-21(38-32-17)15-7-5-6-8-16(15)24(25,26)27/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,30,31) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 620 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50233109
(8-(1-((5-phenyl-1,2,4-oxadiazol-3-yl)methyl)-1H-py...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccccc2)c1 Show InChI InChI=1S/C23H24N8O3/c1-3-10-30-20-18(22(32)31(11-4-2)23(30)33)26-19(27-20)16-12-24-29(13-16)14-17-25-21(34-28-17)15-8-6-5-7-9-15/h5-9,12-13H,3-4,10-11,14H2,1-2H3,(H,26,27) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 630 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176768
(8-(1-((5-(2-chlorophenyl)-1,2,4-oxadiazol-3-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccccc2Cl)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-9-31-20-18(22(33)32(10-4-2)23(31)34)27-19(28-20)14-11-25-30(12-14)13-17-26-21(35-29-17)15-7-5-6-8-16(15)24/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 630 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176739
(4-(3-((4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydr...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccc(cc2)C#N)c1 Show InChI InChI=1S/C24H23N9O3/c1-3-9-32-21-19(23(34)33(10-4-2)24(32)35)28-20(29-21)17-12-26-31(13-17)14-18-27-22(36-30-18)16-7-5-15(11-25)6-8-16/h5-8,12-13H,3-4,9-10,14H2,1-2H3,(H,28,29) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 640 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176752
(8-(1-((3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2cccc(Cl)c2)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-8-31-21-18(22(33)32(9-4-2)23(31)34)27-19(28-21)15-11-25-30(12-15)13-17-26-20(29-35-17)14-6-5-7-16(24)10-14/h5-7,10-12H,3-4,8-9,13H2,1-2H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 652 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176740
(8-(1-((3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccc(Cl)cc2)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-9-31-21-18(22(33)32(10-4-2)23(31)34)27-19(28-21)15-11-25-30(12-15)13-17-26-20(29-35-17)14-5-7-16(24)8-6-14/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 740 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176741
(8-(1-((5-(3-methoxyphenyl)-1,2,4-oxadiazol-3-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2cccc(OC)c2)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-9-31-21-19(23(33)32(10-5-2)24(31)34)27-20(28-21)16-12-25-30(13-16)14-18-26-22(36-29-18)15-7-6-8-17(11-15)35-3/h6-8,11-13H,4-5,9-10,14H2,1-3H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 810 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176762
(8-(1-((5-(2-methoxyphenyl)-1,2,4-oxadiazol-3-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccccc2OC)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-10-31-21-19(23(33)32(11-5-2)24(31)34)27-20(28-21)15-12-25-30(13-15)14-18-26-22(36-29-18)16-8-6-7-9-17(16)35-3/h6-9,12-13H,4-5,10-11,14H2,1-3H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 930 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176757
(4-(5-((4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydr...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccc(cc2)C#N)c1 Show InChI InChI=1S/C24H23N9O3/c1-3-9-32-22-19(23(34)33(10-4-2)24(32)35)28-20(29-22)17-12-26-31(13-17)14-18-27-21(30-36-18)16-7-5-15(11-25)6-8-16/h5-8,12-13H,3-4,9-10,14H2,1-2H3,(H,28,29) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 950 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176737
(1,3-dipropyl-8-(1-((3-(3-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2cccc(c2)C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-8-34-21-18(22(36)35(9-4-2)23(34)37)30-19(31-21)15-11-28-33(12-15)13-17-29-20(32-38-17)14-6-5-7-16(10-14)24(25,26)27/h5-7,10-12H,3-4,8-9,13H2,1-2H3,(H,30,31) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 960 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176766
(1,3-dipropyl-8-(1-((3-m-tolyl-1,2,4-oxadiazol-5-yl...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2cccc(C)c2)c1 Show InChI InChI=1S/C24H26N8O3/c1-4-9-31-22-19(23(33)32(10-5-2)24(31)34)27-20(28-22)17-12-25-30(13-17)14-18-26-21(29-35-18)16-8-6-7-15(3)11-16/h6-8,11-13H,4-5,9-10,14H2,1-3H3,(H,27,28) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 970 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50233109
(8-(1-((5-phenyl-1,2,4-oxadiazol-3-yl)methyl)-1H-py...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccccc2)c1 Show InChI InChI=1S/C23H24N8O3/c1-3-10-30-20-18(22(32)31(11-4-2)23(30)33)26-19(27-20)16-12-24-29(13-16)14-17-25-21(34-28-17)15-8-6-5-7-9-15/h5-9,12-13H,3-4,10-11,14H2,1-2H3,(H,26,27) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176751
(8-(1-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)-1H-py...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccccc2)c1 Show InChI InChI=1S/C23H24N8O3/c1-3-10-30-21-18(22(32)31(11-4-2)23(30)33)26-19(27-21)16-12-24-29(13-16)14-17-25-20(28-34-17)15-8-6-5-7-9-15/h5-9,12-13H,3-4,10-11,14H2,1-2H3,(H,26,27) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176736
(CHEMBL200780 | N-(2-chlorophenyl)-2-(4-(2,6-dioxo-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(CC(=O)Nc2ccccc2Cl)c1 Show InChI InChI=1S/C22H24ClN7O3/c1-3-9-29-20-18(21(32)30(10-4-2)22(29)33)26-19(27-20)14-11-24-28(12-14)13-17(31)25-16-8-6-5-7-15(16)23/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,25,31)(H,26,27) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176755
(1,3-dipropyl-8-(1-((5-(4-(trifluoromethyl)phenyl)i...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccc(cc2)C(F)(F)F)c1 Show InChI InChI=1S/C25H24F3N7O3/c1-3-9-34-22-20(23(36)35(10-4-2)24(34)37)30-21(31-22)16-12-29-33(13-16)14-18-11-19(38-32-18)15-5-7-17(8-6-15)25(26,27)28/h5-8,11-13H,3-4,9-10,14H2,1-2H3,(H,30,31) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176754
(8-(1-((5-(4-chlorophenyl)isoxazol-3-yl)methyl)-1H-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccc(Cl)cc2)c1 Show InChI InChI=1S/C24H24ClN7O3/c1-3-9-31-22-20(23(33)32(10-4-2)24(31)34)27-21(28-22)16-12-26-30(13-16)14-18-11-19(35-29-18)15-5-7-17(25)8-6-15/h5-8,11-13H,3-4,9-10,14H2,1-2H3,(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176757
(4-(5-((4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydr...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccc(cc2)C#N)c1 Show InChI InChI=1S/C24H23N9O3/c1-3-9-32-22-19(23(34)33(10-4-2)24(32)35)28-20(29-22)17-12-26-31(13-17)14-18-27-21(30-36-18)16-7-5-15(11-25)6-8-16/h5-8,12-13H,3-4,9-10,14H2,1-2H3,(H,28,29) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176756
(1,3-dipropyl-8-(1-((3-(4-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccc(cc2)C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-9-34-21-18(22(36)35(10-4-2)23(34)37)30-19(31-21)15-11-28-33(12-15)13-17-29-20(32-38-17)14-5-7-16(8-6-14)24(25,26)27/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,30,31) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176738
(1,3-dipropyl-8-(1-((5-(4-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccc(cc2)C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-9-34-20-18(22(36)35(10-4-2)23(34)37)30-19(31-20)15-11-28-33(12-15)13-17-29-21(38-32-17)14-5-7-16(8-6-14)24(25,26)27/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,30,31) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176766
(1,3-dipropyl-8-(1-((3-m-tolyl-1,2,4-oxadiazol-5-yl...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2cccc(C)c2)c1 Show InChI InChI=1S/C24H26N8O3/c1-4-9-31-22-19(23(33)32(10-5-2)24(31)34)27-20(28-22)17-12-25-30(13-17)14-18-26-21(29-35-18)16-8-6-7-15(3)11-16/h6-8,11-13H,4-5,9-10,14H2,1-3H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50233091
(8-(1-((5-phenylisoxazol-3-yl)methyl)-1H-pyrazol-4-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccccc2)c1 Show InChI InChI=1S/C24H25N7O3/c1-3-10-30-22-20(23(32)31(11-4-2)24(30)33)26-21(27-22)17-13-25-29(14-17)15-18-12-19(34-28-18)16-8-6-5-7-9-16/h5-9,12-14H,3-4,10-11,15H2,1-2H3,(H,26,27) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176744
(8-(1-((3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccc(OC)cc2)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-10-31-22-19(23(33)32(11-5-2)24(31)34)27-20(28-22)16-12-25-30(13-16)14-18-26-21(29-36-18)15-6-8-17(35-3)9-7-15/h6-9,12-13H,4-5,10-11,14H2,1-3H3,(H,27,28) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176736
(CHEMBL200780 | N-(2-chlorophenyl)-2-(4-(2,6-dioxo-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(CC(=O)Nc2ccccc2Cl)c1 Show InChI InChI=1S/C22H24ClN7O3/c1-3-9-29-20-18(21(32)30(10-4-2)22(29)33)26-19(27-20)14-11-24-28(12-14)13-17(31)25-16-8-6-5-7-15(16)23/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,25,31)(H,26,27) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176745
(8-(1-((3-(2-methoxyphenyl)-1,2,4-oxadiazol-5-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccccc2OC)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-10-31-22-19(23(33)32(11-5-2)24(31)34)27-20(28-22)15-12-25-30(13-15)14-18-26-21(29-36-18)16-8-6-7-9-17(16)35-3/h6-9,12-13H,4-5,10-11,14H2,1-3H3,(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176755
(1,3-dipropyl-8-(1-((5-(4-(trifluoromethyl)phenyl)i...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccc(cc2)C(F)(F)F)c1 Show InChI InChI=1S/C25H24F3N7O3/c1-3-9-34-22-20(23(36)35(10-4-2)24(34)37)30-21(31-22)16-12-29-33(13-16)14-18-11-19(38-32-18)15-5-7-17(8-6-15)25(26,27)28/h5-8,11-13H,3-4,9-10,14H2,1-2H3,(H,30,31) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50233109
(8-(1-((5-phenyl-1,2,4-oxadiazol-3-yl)methyl)-1H-py...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccccc2)c1 Show InChI InChI=1S/C23H24N8O3/c1-3-10-30-20-18(22(32)31(11-4-2)23(30)33)26-19(27-20)16-12-24-29(13-16)14-17-25-21(34-28-17)15-8-6-5-7-9-15/h5-9,12-13H,3-4,10-11,14H2,1-2H3,(H,26,27) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176759
(1,3-dipropyl-8-(1-((5-(3-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2cccc(c2)C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-8-34-20-18(22(36)35(9-4-2)23(34)37)30-19(31-20)15-11-28-33(12-15)13-17-29-21(38-32-17)14-6-5-7-16(10-14)24(25,26)27/h5-7,10-12H,3-4,8-9,13H2,1-2H3,(H,30,31) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176740
(8-(1-((3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccc(Cl)cc2)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-9-31-21-18(22(33)32(10-4-2)23(31)34)27-19(28-21)15-11-25-30(12-15)13-17-26-20(29-35-17)14-5-7-16(24)8-6-14/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50233091
(8-(1-((5-phenylisoxazol-3-yl)methyl)-1H-pyrazol-4-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccccc2)c1 Show InChI InChI=1S/C24H25N7O3/c1-3-10-30-22-20(23(32)31(11-4-2)24(30)33)26-21(27-22)17-13-25-29(14-17)15-18-12-19(34-28-18)16-8-6-5-7-9-16/h5-9,12-14H,3-4,10-11,15H2,1-2H3,(H,26,27) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176743
(1,3-dipropyl-8-(1-((5-(2-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccccc2C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-9-34-20-18(22(36)35(10-4-2)23(34)37)30-19(31-20)14-11-28-33(12-14)13-17-29-21(38-32-17)15-7-5-6-8-16(15)24(25,26)27/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,30,31) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176745
(8-(1-((3-(2-methoxyphenyl)-1,2,4-oxadiazol-5-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccccc2OC)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-10-31-22-19(23(33)32(11-5-2)24(31)34)27-20(28-22)15-12-25-30(13-15)14-18-26-21(29-36-18)16-8-6-7-9-17(16)35-3/h6-9,12-13H,4-5,10-11,14H2,1-3H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176763
(8-(1-((5-(4-methoxyphenyl)isoxazol-3-yl)methyl)-1H...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccc(OC)cc2)c1 Show InChI InChI=1S/C25H27N7O4/c1-4-10-31-23-21(24(33)32(11-5-2)25(31)34)27-22(28-23)17-13-26-30(14-17)15-18-12-20(36-29-18)16-6-8-19(35-3)9-7-16/h6-9,12-14H,4-5,10-11,15H2,1-3H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176741
(8-(1-((5-(3-methoxyphenyl)-1,2,4-oxadiazol-3-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2cccc(OC)c2)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-9-31-21-19(23(33)32(10-5-2)24(31)34)27-20(28-21)16-12-25-30(13-16)14-18-26-22(36-29-18)15-7-6-8-17(11-15)35-3/h6-8,11-13H,4-5,9-10,14H2,1-3H3,(H,27,28) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176749
(8-(1-((3-(3-methoxyphenyl)-1,2,4-oxadiazol-5-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2cccc(OC)c2)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-9-31-22-19(23(33)32(10-5-2)24(31)34)27-20(28-22)16-12-25-30(13-16)14-18-26-21(29-36-18)15-7-6-8-17(11-15)35-3/h6-8,11-13H,4-5,9-10,14H2,1-3H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176747
(8-(1-((5-(4-methoxyphenyl)-1,2,4-oxadiazol-3-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccc(OC)cc2)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-10-31-21-19(23(33)32(11-5-2)24(31)34)27-20(28-21)16-12-25-30(13-16)14-18-26-22(36-29-18)15-6-8-17(35-3)9-7-15/h6-9,12-13H,4-5,10-11,14H2,1-3H3,(H,27,28) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176755
(1,3-dipropyl-8-(1-((5-(4-(trifluoromethyl)phenyl)i...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccc(cc2)C(F)(F)F)c1 Show InChI InChI=1S/C25H24F3N7O3/c1-3-9-34-22-20(23(36)35(10-4-2)24(34)37)30-21(31-22)16-12-29-33(13-16)14-18-11-19(38-32-18)15-5-7-17(8-6-15)25(26,27)28/h5-8,11-13H,3-4,9-10,14H2,1-2H3,(H,30,31) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176761
(8-(1-((5-(2-chlorophenyl)isoxazol-3-yl)methyl)-1H-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccccc2Cl)c1 Show InChI InChI=1S/C24H24ClN7O3/c1-3-9-31-22-20(23(33)32(10-4-2)24(31)34)27-21(28-22)15-12-26-30(13-15)14-16-11-19(35-29-16)17-7-5-6-8-18(17)25/h5-8,11-13H,3-4,9-10,14H2,1-2H3,(H,27,28) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176768
(8-(1-((5-(2-chlorophenyl)-1,2,4-oxadiazol-3-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccccc2Cl)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-9-31-20-18(22(33)32(10-4-2)23(31)34)27-19(28-20)14-11-25-30(12-14)13-17-26-21(35-29-17)15-7-5-6-8-16(15)24/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176769
(8-(1-((3-(2-chlorophenyl)-1,2,4-oxadiazol-5-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccccc2Cl)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-9-31-21-18(22(33)32(10-4-2)23(31)34)27-19(28-21)14-11-25-30(12-14)13-17-26-20(29-35-17)15-7-5-6-8-16(15)24/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176769
(8-(1-((3-(2-chlorophenyl)-1,2,4-oxadiazol-5-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccccc2Cl)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-9-31-21-18(22(33)32(10-4-2)23(31)34)27-19(28-21)14-11-25-30(12-14)13-17-26-20(29-35-17)15-7-5-6-8-16(15)24/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176767
(1,3-dipropyl-8-(1-((3-p-tolyl-1,2,4-oxadiazol-5-yl...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccc(C)cc2)c1 Show InChI InChI=1S/C24H26N8O3/c1-4-10-31-22-19(23(33)32(11-5-2)24(31)34)27-20(28-22)17-12-25-30(13-17)14-18-26-21(29-35-18)16-8-6-15(3)7-9-16/h6-9,12-13H,4-5,10-11,14H2,1-3H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176761
(8-(1-((5-(2-chlorophenyl)isoxazol-3-yl)methyl)-1H-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccccc2Cl)c1 Show InChI InChI=1S/C24H24ClN7O3/c1-3-9-31-22-20(23(33)32(10-4-2)24(31)34)27-21(28-22)15-12-26-30(13-15)14-16-11-19(35-29-16)17-7-5-6-8-18(17)25/h5-8,11-13H,3-4,9-10,14H2,1-2H3,(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176748
(8-(1-((5-(4-chlorophenyl)-1,2,4-oxadiazol-3-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccc(Cl)cc2)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-9-31-20-18(22(33)32(10-4-2)23(31)34)27-19(28-20)15-11-25-30(12-15)13-17-26-21(35-29-17)14-5-7-16(24)8-6-14/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176763
(8-(1-((5-(4-methoxyphenyl)isoxazol-3-yl)methyl)-1H...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccc(OC)cc2)c1 Show InChI InChI=1S/C25H27N7O4/c1-4-10-31-23-21(24(33)32(11-5-2)25(31)34)27-22(28-23)17-13-26-30(14-17)15-18-12-20(36-29-18)16-6-8-19(35-3)9-7-16/h6-9,12-14H,4-5,10-11,15H2,1-3H3,(H,27,28) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176744
(8-(1-((3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccc(OC)cc2)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-10-31-22-19(23(33)32(11-5-2)24(31)34)27-20(28-22)16-12-25-30(13-16)14-18-26-21(29-36-18)15-6-8-17(35-3)9-7-15/h6-9,12-13H,4-5,10-11,14H2,1-3H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176767
(1,3-dipropyl-8-(1-((3-p-tolyl-1,2,4-oxadiazol-5-yl...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccc(C)cc2)c1 Show InChI InChI=1S/C24H26N8O3/c1-4-10-31-22-19(23(33)32(11-5-2)24(31)34)27-20(28-22)17-12-25-30(13-17)14-18-26-21(29-35-18)16-8-6-15(3)7-9-16/h6-9,12-13H,4-5,10-11,14H2,1-3H3,(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176746
(8-(1-((5-(3-chlorophenyl)-1,2,4-oxadiazol-3-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2cccc(Cl)c2)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-8-31-20-18(22(33)32(9-4-2)23(31)34)27-19(28-20)15-11-25-30(12-15)13-17-26-21(35-29-17)14-6-5-7-16(24)10-14/h5-7,10-12H,3-4,8-9,13H2,1-2H3,(H,27,28) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176746
(8-(1-((5-(3-chlorophenyl)-1,2,4-oxadiazol-3-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2cccc(Cl)c2)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-8-31-20-18(22(33)32(9-4-2)23(31)34)27-19(28-20)15-11-25-30(12-15)13-17-26-21(35-29-17)14-6-5-7-16(24)10-14/h5-7,10-12H,3-4,8-9,13H2,1-2H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176753
(8-(1-((5-(2-methoxyphenyl)isoxazol-3-yl)methyl)-1H...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccccc2OC)c1 Show InChI InChI=1S/C25H27N7O4/c1-4-10-31-23-21(24(33)32(11-5-2)25(31)34)27-22(28-23)16-13-26-30(14-16)15-17-12-20(36-29-17)18-8-6-7-9-19(18)35-3/h6-9,12-14H,4-5,10-11,15H2,1-3H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 3.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176754
(8-(1-((5-(4-chlorophenyl)isoxazol-3-yl)methyl)-1H-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccc(Cl)cc2)c1 Show InChI InChI=1S/C24H24ClN7O3/c1-3-9-31-22-20(23(33)32(10-4-2)24(31)34)27-21(28-22)16-12-26-30(13-16)14-18-11-19(35-29-18)15-5-7-17(25)8-6-15/h5-8,11-13H,3-4,9-10,14H2,1-2H3,(H,27,28) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 3.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176756
(1,3-dipropyl-8-(1-((3-(4-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccc(cc2)C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-9-34-21-18(22(36)35(10-4-2)23(34)37)30-19(31-21)15-11-28-33(12-15)13-17-29-20(32-38-17)14-5-7-16(8-6-14)24(25,26)27/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,30,31) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 3.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176762
(8-(1-((5-(2-methoxyphenyl)-1,2,4-oxadiazol-3-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccccc2OC)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-10-31-21-19(23(33)32(11-5-2)24(31)34)27-20(28-21)15-12-25-30(13-15)14-18-26-22(36-29-18)16-8-6-7-9-17(16)35-3/h6-9,12-13H,4-5,10-11,14H2,1-3H3,(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 3.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176765
(8-(1-((5-(3-methoxyphenyl)isoxazol-3-yl)methyl)-1H...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2cccc(OC)c2)c1 Show InChI InChI=1S/C25H27N7O4/c1-4-9-31-23-21(24(33)32(10-5-2)25(31)34)27-22(28-23)17-13-26-30(14-17)15-18-12-20(36-29-18)16-7-6-8-19(11-16)35-3/h6-8,11-14H,4-5,9-10,15H2,1-3H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 3.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176737
(1,3-dipropyl-8-(1-((3-(3-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2cccc(c2)C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-8-34-21-18(22(36)35(9-4-2)23(34)37)30-19(31-21)15-11-28-33(12-15)13-17-29-20(32-38-17)14-6-5-7-16(10-14)24(25,26)27/h5-7,10-12H,3-4,8-9,13H2,1-2H3,(H,30,31) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 3.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176750
(1,3-dipropyl-8-(1-((5-(2-(trifluoromethyl)phenyl)i...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccccc2C(F)(F)F)c1 Show InChI InChI=1S/C25H24F3N7O3/c1-3-9-34-22-20(23(36)35(10-4-2)24(34)37)30-21(31-22)15-12-29-33(13-15)14-16-11-19(38-32-16)17-7-5-6-8-18(17)25(26,27)28/h5-8,11-13H,3-4,9-10,14H2,1-2H3,(H,30,31) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 3.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176747
(8-(1-((5-(4-methoxyphenyl)-1,2,4-oxadiazol-3-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccc(OC)cc2)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-10-31-21-19(23(33)32(11-5-2)24(31)34)27-20(28-21)16-12-25-30(13-16)14-18-26-22(36-29-18)15-6-8-17(35-3)9-7-15/h6-9,12-13H,4-5,10-11,14H2,1-3H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 3.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176750
(1,3-dipropyl-8-(1-((5-(2-(trifluoromethyl)phenyl)i...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccccc2C(F)(F)F)c1 Show InChI InChI=1S/C25H24F3N7O3/c1-3-9-34-22-20(23(36)35(10-4-2)24(34)37)30-21(31-22)15-12-29-33(13-15)14-16-11-19(38-32-16)17-7-5-6-8-18(17)25(26,27)28/h5-8,11-13H,3-4,9-10,14H2,1-2H3,(H,30,31) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 4.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176764
(8-(1-((5-(3-chlorophenyl)isoxazol-3-yl)methyl)-1H-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2cccc(Cl)c2)c1 Show InChI InChI=1S/C24H24ClN7O3/c1-3-8-31-22-20(23(33)32(9-4-2)24(31)34)27-21(28-22)16-12-26-30(13-16)14-18-11-19(35-29-18)15-6-5-7-17(25)10-15/h5-7,10-13H,3-4,8-9,14H2,1-2H3,(H,27,28) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 4.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176764
(8-(1-((5-(3-chlorophenyl)isoxazol-3-yl)methyl)-1H-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2cccc(Cl)c2)c1 Show InChI InChI=1S/C24H24ClN7O3/c1-3-8-31-22-20(23(33)32(9-4-2)24(31)34)27-21(28-22)16-12-26-30(13-16)14-18-11-19(35-29-18)15-6-5-7-17(25)10-15/h5-7,10-13H,3-4,8-9,14H2,1-2H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 4.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176753
(8-(1-((5-(2-methoxyphenyl)isoxazol-3-yl)methyl)-1H...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccccc2OC)c1 Show InChI InChI=1S/C25H27N7O4/c1-4-10-31-23-21(24(33)32(11-5-2)25(31)34)27-22(28-23)16-13-26-30(14-16)15-17-12-20(36-29-17)18-8-6-7-9-19(18)35-3/h6-9,12-14H,4-5,10-11,15H2,1-3H3,(H,27,28) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 4.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176738
(1,3-dipropyl-8-(1-((5-(4-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccc(cc2)C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-9-34-20-18(22(36)35(10-4-2)23(34)37)30-19(31-20)15-11-28-33(12-15)13-17-29-21(38-32-17)14-5-7-16(8-6-14)24(25,26)27/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,30,31) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176746
(8-(1-((5-(3-chlorophenyl)-1,2,4-oxadiazol-3-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2cccc(Cl)c2)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-8-31-20-18(22(33)32(9-4-2)23(31)34)27-19(28-20)15-11-25-30(12-15)13-17-26-21(35-29-17)14-6-5-7-16(24)10-14/h5-7,10-12H,3-4,8-9,13H2,1-2H3,(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176737
(1,3-dipropyl-8-(1-((3-(3-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2cccc(c2)C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-8-34-21-18(22(36)35(9-4-2)23(34)37)30-19(31-21)15-11-28-33(12-15)13-17-29-20(32-38-17)14-6-5-7-16(10-14)24(25,26)27/h5-7,10-12H,3-4,8-9,13H2,1-2H3,(H,30,31) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176759
(1,3-dipropyl-8-(1-((5-(3-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2cccc(c2)C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-8-34-20-18(22(36)35(9-4-2)23(34)37)30-19(31-20)15-11-28-33(12-15)13-17-29-21(38-32-17)14-6-5-7-16(10-14)24(25,26)27/h5-7,10-12H,3-4,8-9,13H2,1-2H3,(H,30,31) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176763
(8-(1-((5-(4-methoxyphenyl)isoxazol-3-yl)methyl)-1H...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccc(OC)cc2)c1 Show InChI InChI=1S/C25H27N7O4/c1-4-10-31-23-21(24(33)32(11-5-2)25(31)34)27-22(28-23)17-13-26-30(14-17)15-18-12-20(36-29-18)16-6-8-19(35-3)9-7-16/h6-9,12-14H,4-5,10-11,15H2,1-3H3,(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176739
(4-(3-((4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydr...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccc(cc2)C#N)c1 Show InChI InChI=1S/C24H23N9O3/c1-3-9-32-21-19(23(34)33(10-4-2)24(32)35)28-20(29-21)17-12-26-31(13-17)14-18-27-22(36-30-18)16-7-5-15(11-25)6-8-16/h5-8,12-13H,3-4,9-10,14H2,1-2H3,(H,28,29) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176764
(8-(1-((5-(3-chlorophenyl)isoxazol-3-yl)methyl)-1H-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2cccc(Cl)c2)c1 Show InChI InChI=1S/C24H24ClN7O3/c1-3-8-31-22-20(23(33)32(9-4-2)24(31)34)27-21(28-22)16-12-26-30(13-16)14-18-11-19(35-29-18)15-6-5-7-17(25)10-15/h5-7,10-13H,3-4,8-9,14H2,1-2H3,(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176757
(4-(5-((4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydr...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccc(cc2)C#N)c1 Show InChI InChI=1S/C24H23N9O3/c1-3-9-32-22-19(23(34)33(10-4-2)24(32)35)28-20(29-22)17-12-26-31(13-17)14-18-27-21(30-36-18)16-7-5-15(11-25)6-8-16/h5-8,12-13H,3-4,9-10,14H2,1-2H3,(H,28,29) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176743
(1,3-dipropyl-8-(1-((5-(2-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccccc2C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-9-34-20-18(22(36)35(10-4-2)23(34)37)30-19(31-20)14-11-28-33(12-14)13-17-29-21(38-32-17)15-7-5-6-8-16(15)24(25,26)27/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,30,31) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176750
(1,3-dipropyl-8-(1-((5-(2-(trifluoromethyl)phenyl)i...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccccc2C(F)(F)F)c1 Show InChI InChI=1S/C25H24F3N7O3/c1-3-9-34-22-20(23(36)35(10-4-2)24(34)37)30-21(31-22)15-12-29-33(13-15)14-16-11-19(38-32-16)17-7-5-6-8-18(17)25(26,27)28/h5-8,11-13H,3-4,9-10,14H2,1-2H3,(H,30,31) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176747
(8-(1-((5-(4-methoxyphenyl)-1,2,4-oxadiazol-3-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccc(OC)cc2)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-10-31-21-19(23(33)32(11-5-2)24(31)34)27-20(28-21)16-12-25-30(13-16)14-18-26-22(36-29-18)15-6-8-17(35-3)9-7-15/h6-9,12-13H,4-5,10-11,14H2,1-3H3,(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176744
(8-(1-((3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccc(OC)cc2)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-10-31-22-19(23(33)32(11-5-2)24(31)34)27-20(28-22)16-12-25-30(13-16)14-18-26-21(29-36-18)15-6-8-17(35-3)9-7-15/h6-9,12-13H,4-5,10-11,14H2,1-3H3,(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176756
(1,3-dipropyl-8-(1-((3-(4-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccc(cc2)C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-9-34-21-18(22(36)35(10-4-2)23(34)37)30-19(31-21)15-11-28-33(12-15)13-17-29-20(32-38-17)14-5-7-16(8-6-14)24(25,26)27/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,30,31) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176766
(1,3-dipropyl-8-(1-((3-m-tolyl-1,2,4-oxadiazol-5-yl...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2cccc(C)c2)c1 Show InChI InChI=1S/C24H26N8O3/c1-4-9-31-22-19(23(33)32(10-5-2)24(31)34)27-20(28-22)17-12-25-30(13-17)14-18-26-21(29-35-18)16-8-6-7-15(3)11-16/h6-8,11-13H,4-5,9-10,14H2,1-3H3,(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176765
(8-(1-((5-(3-methoxyphenyl)isoxazol-3-yl)methyl)-1H...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2cccc(OC)c2)c1 Show InChI InChI=1S/C25H27N7O4/c1-4-9-31-23-21(24(33)32(10-5-2)25(31)34)27-22(28-23)17-13-26-30(14-17)15-18-12-20(36-29-18)16-7-6-8-19(11-16)35-3/h6-8,11-14H,4-5,9-10,15H2,1-3H3,(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176752
(8-(1-((3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2cccc(Cl)c2)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-8-31-21-18(22(33)32(9-4-2)23(31)34)27-19(28-21)15-11-25-30(12-15)13-17-26-20(29-35-17)14-6-5-7-16(24)10-14/h5-7,10-12H,3-4,8-9,13H2,1-2H3,(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176749
(8-(1-((3-(3-methoxyphenyl)-1,2,4-oxadiazol-5-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2cccc(OC)c2)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-9-31-22-19(23(33)32(10-5-2)24(31)34)27-20(28-22)16-12-25-30(13-16)14-18-26-21(29-36-18)15-7-6-8-17(11-15)35-3/h6-8,11-13H,4-5,9-10,14H2,1-3H3,(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176753
(8-(1-((5-(2-methoxyphenyl)isoxazol-3-yl)methyl)-1H...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccccc2OC)c1 Show InChI InChI=1S/C25H27N7O4/c1-4-10-31-23-21(24(33)32(11-5-2)25(31)34)27-22(28-23)16-13-26-30(14-16)15-17-12-20(36-29-17)18-8-6-7-9-19(18)35-3/h6-9,12-14H,4-5,10-11,15H2,1-3H3,(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176748
(8-(1-((5-(4-chlorophenyl)-1,2,4-oxadiazol-3-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccc(Cl)cc2)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-9-31-20-18(22(33)32(10-4-2)23(31)34)27-19(28-20)15-11-25-30(12-15)13-17-26-21(35-29-17)14-5-7-16(24)8-6-14/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176742
(1,3-dipropyl-8-(1-((3-(2-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccccc2C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-9-34-21-18(22(36)35(10-4-2)23(34)37)30-19(31-21)14-11-28-33(12-14)13-17-29-20(32-38-17)15-7-5-6-8-16(15)24(25,26)27/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,30,31) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176765
(8-(1-((5-(3-methoxyphenyl)isoxazol-3-yl)methyl)-1H...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2cccc(OC)c2)c1 Show InChI InChI=1S/C25H27N7O4/c1-4-9-31-23-21(24(33)32(10-5-2)25(31)34)27-22(28-23)17-13-26-30(14-17)15-18-12-20(36-29-18)16-7-6-8-19(11-16)35-3/h6-8,11-14H,4-5,9-10,15H2,1-3H3,(H,27,28) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A2a
(Homo sapiens (Human)) | BDBM50176741
(8-(1-((5-(3-methoxyphenyl)-1,2,4-oxadiazol-3-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2cccc(OC)c2)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-9-31-21-19(23(33)32(10-5-2)24(31)34)27-20(28-21)16-12-25-30(13-16)14-18-26-22(36-29-18)15-7-6-8-17(11-15)35-3/h6-8,11-13H,4-5,9-10,14H2,1-3H3,(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]ZM241385 from Adenosine A2A receptor expressed in HEK cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176759
(1,3-dipropyl-8-(1-((5-(3-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2cccc(c2)C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-8-34-20-18(22(36)35(9-4-2)23(34)37)30-19(31-20)15-11-28-33(12-15)13-17-29-21(38-32-17)14-6-5-7-16(10-14)24(25,26)27/h5-7,10-12H,3-4,8-9,13H2,1-2H3,(H,30,31) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >6.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176761
(8-(1-((5-(2-chlorophenyl)isoxazol-3-yl)methyl)-1H-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2cc(on2)-c2ccccc2Cl)c1 Show InChI InChI=1S/C24H24ClN7O3/c1-3-9-31-22-20(23(33)32(10-4-2)24(31)34)27-21(28-22)15-12-26-30(13-15)14-16-11-19(35-29-16)17-7-5-6-8-18(17)25/h5-8,11-13H,3-4,9-10,14H2,1-2H3,(H,27,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >6.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A1
(Homo sapiens (Human)) | BDBM50176738
(1,3-dipropyl-8-(1-((5-(4-(trifluoromethyl)phenyl)-...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccc(cc2)C(F)(F)F)c1 Show InChI InChI=1S/C24H23F3N8O3/c1-3-9-34-20-18(22(36)35(10-4-2)23(34)37)30-19(31-20)15-11-28-33(12-15)13-17-29-21(38-32-17)14-5-7-16(8-6-14)24(25,26)27/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,30,31) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >6.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [3H]CPX from Adenosine A1 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176762
(8-(1-((5-(2-methoxyphenyl)-1,2,4-oxadiazol-3-yl)me...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccccc2OC)c1 Show InChI InChI=1S/C24H26N8O4/c1-4-10-31-21-19(23(33)32(11-5-2)24(31)34)27-20(28-21)15-12-25-30(13-15)14-18-26-22(36-29-18)16-8-6-7-9-17(16)35-3/h6-9,12-13H,4-5,10-11,14H2,1-3H3,(H,27,28) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >8.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176748
(8-(1-((5-(4-chlorophenyl)-1,2,4-oxadiazol-3-yl)met...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2noc(n2)-c2ccc(Cl)cc2)c1 Show InChI InChI=1S/C23H23ClN8O3/c1-3-9-31-20-18(22(33)32(10-4-2)23(31)34)27-19(28-20)15-11-25-30(12-15)13-17-26-21(35-29-17)14-5-7-16(24)8-6-14/h5-8,11-12H,3-4,9-10,13H2,1-2H3,(H,27,28) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >8.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Adenosine receptor A3
(Homo sapiens (Human)) | BDBM50176767
(1,3-dipropyl-8-(1-((3-p-tolyl-1,2,4-oxadiazol-5-yl...)Show SMILES CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1cnn(Cc2nc(no2)-c2ccc(C)cc2)c1 Show InChI InChI=1S/C24H26N8O3/c1-4-10-31-22-19(23(33)32(11-5-2)24(31)34)27-20(28-22)17-12-25-30(13-17)14-18-26-21(29-35-18)16-8-6-15(3)7-9-16/h6-9,12-13H,4-5,10-11,14H2,1-3H3,(H,27,28) | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 8.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
CV Therapeutics Inc.
Curated by ChEMBL
| Assay Description
Displacement of [125I]AB-MECA from Adenosine A3 receptor expressed in CHO cells |
Bioorg Med Chem Lett 16: 302-6 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.002
BindingDB Entry DOI: 10.7270/Q2154GM1 |
More data for this
Ligand-Target Pair | |
Search and Browse
